title: Cutaneous lymphoid hyperplasia associated with Leishmania panamensis infection.
authors.forename: Sebastiano
authors.initials: S
authors.lastname: Recalcati
authors.forename: Pamela
authors.initials: P
authors.lastname: Vezzoli
authors.forename: Valentina
authors.initials: V
authors.lastname: Girgenti
authors.forename: Luigia
authors.initials: L
authors.lastname: Venegoni
authors.forename: Stefano
authors.initials: S
authors.lastname: Veraldi
authors.forename: Emilio
authors.initials: E
authors.lastname: Berti
mesh_terms: D000284:Administration, Oral; D000368:Aged; D000981:Antiprotozoal Agents / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D007654:Ketoconazole / Q000008:administration & dosage; D018334:Leishmania guyanensis / Q000302:isolation & purification*; D007897:Leishmaniasis, Mucocutaneous / Q000150:complications / Q000188:drug therapy / Q000469:parasitology* / Q000473:pathology; D010419:Pentamidine / Q000008:administration & dosage; D019310:Pseudolymphoma / Q000188:drug therapy / Q000469:parasitology* / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D000981:Antiprotozoal Agents; D010419:Pentamidine; D007654:Ketoconazole